Intra-Cellular downgraded to Equal Weight from Overweight at Morgan Stanley

Morgan Stanley downgraded Intra-Cellular (ITCI) to Equal Weight from Overweight with a price target of $132, up from $102, after Johnson & Johnson (JNJ) announced that it has entered into an agreement to acquire Intra-Cellular. The firm’s revised rating is based on the expectation that the deal goes through as announced.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue